Cargando…
Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016
Puerto Rico has been heavily impacted by Zika virus, a mosquitoborne flavivirus that emerged in the Americas during 2015. Although most persons with Zika virus show no symptoms, the virus can cause neurologic and other complications, including fetal microcephaly. Local Zika virus transmission in Pue...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403024/ https://www.ncbi.nlm.nih.gov/pubmed/28263141 http://dx.doi.org/10.3201/eid2305.161873 |
_version_ | 1783231351336468480 |
---|---|
author | Chevalier, Michelle S. Biggerstaff, Brad J. Basavaraju, Sridhar V. Ocfemia, M. Cheryl Bañez Alsina, Jose O. Climent-Peris, Consuelo Moseley, Robin R. Chung, Koo-Whang Rivera-García, Brenda Bello-Pagán, Melissa Pate, Lisa L. Galel, Susan A. Williamson, Phillip Kuehnert, Matthew J. |
author_facet | Chevalier, Michelle S. Biggerstaff, Brad J. Basavaraju, Sridhar V. Ocfemia, M. Cheryl Bañez Alsina, Jose O. Climent-Peris, Consuelo Moseley, Robin R. Chung, Koo-Whang Rivera-García, Brenda Bello-Pagán, Melissa Pate, Lisa L. Galel, Susan A. Williamson, Phillip Kuehnert, Matthew J. |
author_sort | Chevalier, Michelle S. |
collection | PubMed |
description | Puerto Rico has been heavily impacted by Zika virus, a mosquitoborne flavivirus that emerged in the Americas during 2015. Although most persons with Zika virus show no symptoms, the virus can cause neurologic and other complications, including fetal microcephaly. Local Zika virus transmission in Puerto Rico has been reported since December 2015. To prevent transfusion-associated transmission, local blood collection ceased in March 2016 but resumed in April 2016 after Zika virus screening of blood donations became available. Using data from screening of blood donations collected by the 2 largest blood centers in Puerto Rico during April 3–August 12, 2016, and assuming a 9.9-day duration of viremia, we estimated that 469,321 persons in Puerto Rico were infected during this period, for an estimated cumulative incidence of 12.9%. Results from blood donation screening during arboviral outbreaks can supplement routine clinical and surveillance data for improved targeting of prevention efforts. |
format | Online Article Text |
id | pubmed-5403024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-54030242017-05-12 Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016 Chevalier, Michelle S. Biggerstaff, Brad J. Basavaraju, Sridhar V. Ocfemia, M. Cheryl Bañez Alsina, Jose O. Climent-Peris, Consuelo Moseley, Robin R. Chung, Koo-Whang Rivera-García, Brenda Bello-Pagán, Melissa Pate, Lisa L. Galel, Susan A. Williamson, Phillip Kuehnert, Matthew J. Emerg Infect Dis Research Puerto Rico has been heavily impacted by Zika virus, a mosquitoborne flavivirus that emerged in the Americas during 2015. Although most persons with Zika virus show no symptoms, the virus can cause neurologic and other complications, including fetal microcephaly. Local Zika virus transmission in Puerto Rico has been reported since December 2015. To prevent transfusion-associated transmission, local blood collection ceased in March 2016 but resumed in April 2016 after Zika virus screening of blood donations became available. Using data from screening of blood donations collected by the 2 largest blood centers in Puerto Rico during April 3–August 12, 2016, and assuming a 9.9-day duration of viremia, we estimated that 469,321 persons in Puerto Rico were infected during this period, for an estimated cumulative incidence of 12.9%. Results from blood donation screening during arboviral outbreaks can supplement routine clinical and surveillance data for improved targeting of prevention efforts. Centers for Disease Control and Prevention 2017-05 /pmc/articles/PMC5403024/ /pubmed/28263141 http://dx.doi.org/10.3201/eid2305.161873 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Chevalier, Michelle S. Biggerstaff, Brad J. Basavaraju, Sridhar V. Ocfemia, M. Cheryl Bañez Alsina, Jose O. Climent-Peris, Consuelo Moseley, Robin R. Chung, Koo-Whang Rivera-García, Brenda Bello-Pagán, Melissa Pate, Lisa L. Galel, Susan A. Williamson, Phillip Kuehnert, Matthew J. Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016 |
title | Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016 |
title_full | Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016 |
title_fullStr | Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016 |
title_full_unstemmed | Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016 |
title_short | Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016 |
title_sort | use of blood donor screening data to estimate zika virus incidence, puerto rico, april–august 2016 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403024/ https://www.ncbi.nlm.nih.gov/pubmed/28263141 http://dx.doi.org/10.3201/eid2305.161873 |
work_keys_str_mv | AT chevaliermichelles useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT biggerstaffbradj useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT basavarajusridharv useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT ocfemiamcherylbanez useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT alsinajoseo useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT climentperisconsuelo useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT moseleyrobinr useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT chungkoowhang useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT riveragarciabrenda useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT bellopaganmelissa useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT patelisal useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT galelsusana useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT williamsonphillip useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 AT kuehnertmatthewj useofblooddonorscreeningdatatoestimatezikavirusincidencepuertoricoaprilaugust2016 |